☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Bio-Thera
Bio-Thera Reports the US FDA’s Approval of Avzivi (Biosimilar, Avastin)
December 8, 2023
Bio-Thera Reports the Results for BAT2206 in P-III Trial for the Treatment of Plaque Psoriasis
December 6, 2023
Bio-Thera Reported Positive Results of BAT2206 (biosimilar ustekinumab) in P-III Study for Patients with Plaque Psoriasis
November 29, 2023
Bio-Thera Reports P-I Study Results of BAT8006 for the Treatment of Advanced Solid Tumors
August 14, 2023
Bio-Thera Solutions Reports the NMPA's Acceptance of MAA for BAT1806 (biosimilar, tocilizumab) to Treat Rheumatoid Arthritis
November 16, 2021
PharmaShots Weekly Snapshots (October 18 - 22, 2021)
October 22, 2021
Load more...
Back to Home